Literature DB >> 21780003

In silico prediction of splice-affecting nucleotide variants.

Claude Houdayer1.   

Abstract

It appears that all types of genomic nucleotide variations can be deleterious by affecting normal pre-mRNA splicing via disruption/creation of splice site consensus sequences. As it is neither pertinent nor realistic to perform functional testing for all of these variants, it is important to identify those that could lead to a splice defect in order to restrict experimental transcript analyses to the most appropriate cases. In silico tools designed to provide this type of prediction are available. In this chapter, we present in silico splice tools integrated in the Alamut (Interactive Biosoftware) application and detail their use in routine diagnostic applications. At this time, in silico predictions are useful for variants that decrease the strength of wild-type splice sites or create a cryptic splice site. Importantly, in silico predictions are not sufficient to classify variants as neutral or deleterious: they should be used as part of the decision-making process to detect potential candidates for splicing anomalies, prompting molecular geneticists to carry out transcript analyses in a limited and pertinent number of cases which could be managed in routine settings.

Mesh:

Substances:

Year:  2011        PMID: 21780003     DOI: 10.1007/978-1-61779-176-5_17

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  15 in total

1.  Pathogenic Abnormal Splicing Due to Intronic Deletions that Induce Biophysical Space Constraint for Spliceosome Assembly.

Authors:  Samantha J Bryen; Himanshu Joshi; Frances J Evesson; Cyrille Girard; Roula Ghaoui; Leigh B Waddell; Alison C Testa; Beryl Cummings; Susan Arbuckle; Nicole Graf; Richard Webster; Daniel G MacArthur; Nigel G Laing; Mark R Davis; Reinhard Lührmann; Sandra T Cooper
Journal:  Am J Hum Genet       Date:  2019-08-22       Impact factor: 11.025

2.  Parent-of-origin effect of hypomorphic pathogenic variants and somatic mosaicism impact on phenotypic expression of retinoblastoma.

Authors:  Valentina Imperatore; Anna Maria Pinto; Elisa Gelli; Eva Trevisson; Valeria Morbidoni; Elisa Frullanti; Theodora Hadjistilianou; Sonia De Francesco; Paolo Toti; Elena Gusson; Gaia Roversi; Andrea Accogli; Valeria Capra; Maria Antonietta Mencarelli; Alessandra Renieri; Francesca Ariani
Journal:  Eur J Hum Genet       Date:  2018-04-17       Impact factor: 4.246

3.  Prevalance of BRCA1 and BRCA2 mutations in familial breast cancer patients in Lebanon.

Authors:  Nadine Jalkh; Jinane Nassar-Slaba; Eliane Chouery; Nabiha Salem; Nancy Uhrchammer; Lisa Golmard; Domique Stoppa-Lyonnet; Yves-Jean Bignon; André Mégarbané
Journal:  Hered Cancer Clin Pract       Date:  2012-06-19       Impact factor: 2.857

4.  Targeted next-generation sequencing in steroid-resistant nephrotic syndrome: mutations in multiple glomerular genes may influence disease severity.

Authors:  Gemma Bullich; Daniel Trujillano; Sheila Santín; Stephan Ossowski; Santiago Mendizábal; Gloria Fraga; Álvaro Madrid; Gema Ariceta; José Ballarín; Roser Torra; Xavier Estivill; Elisabet Ars
Journal:  Eur J Hum Genet       Date:  2014-11-19       Impact factor: 4.246

5.  Novel mutation in the CHST6 gene causes macular corneal dystrophy in a black South African family.

Authors:  Nadia Carstens; Susan Williams; Saadiah Goolam; Trevor Carmichael; Ming Sin Cheung; Stine Büchmann-Møller; Marc Sultan; Frank Staedtler; Chao Zou; Peter Swart; Dennis S Rice; Arnaud Lacoste; Kim Paes; Michèle Ramsay
Journal:  BMC Med Genet       Date:  2016-07-20       Impact factor: 2.103

6.  Next-generation sequencing reveals DGUOK mutations in adult patients with mitochondrial DNA multiple deletions.

Authors:  Dario Ronchi; Caterina Garone; Andreina Bordoni; Purificacion Gutierrez Rios; Sarah E Calvo; Michela Ripolone; Michela Ranieri; Mafalda Rizzuti; Luisa Villa; Francesca Magri; Stefania Corti; Nereo Bresolin; Vamsi K Mootha; Maurizio Moggio; Salvatore DiMauro; Giacomo P Comi; Monica Sciacco
Journal:  Brain       Date:  2012-10-04       Impact factor: 13.501

7.  Disruptive CHD8 mutations define a subtype of autism early in development.

Authors:  Raphael Bernier; Christelle Golzio; Bo Xiong; Holly A Stessman; Bradley P Coe; Osnat Penn; Kali Witherspoon; Jennifer Gerdts; Carl Baker; Anneke T Vulto-van Silfhout; Janneke H Schuurs-Hoeijmakers; Marco Fichera; Paolo Bosco; Serafino Buono; Antonino Alberti; Pinella Failla; Hilde Peeters; Jean Steyaert; Lisenka E L M Vissers; Ludmila Francescatto; Heather C Mefford; Jill A Rosenfeld; Trygve Bakken; Brian J O'Roak; Matthew Pawlus; Randall Moon; Jay Shendure; David G Amaral; Ed Lein; Julia Rankin; Corrado Romano; Bert B A de Vries; Nicholas Katsanis; Evan E Eichler
Journal:  Cell       Date:  2014-07-03       Impact factor: 41.582

8.  Comparative in vitro and in silico analyses of variants in splicing regions of BRCA1 and BRCA2 genes and characterization of novel pathogenic mutations.

Authors:  Mara Colombo; Giovanna De Vecchi; Laura Caleca; Claudia Foglia; Carla B Ripamonti; Filomena Ficarazzi; Monica Barile; Liliana Varesco; Bernard Peissel; Siranoush Manoukian; Paolo Radice
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

9.  Association of Germline CHEK2 Gene Variants with Risk and Prognosis of Non-Hodgkin Lymphoma.

Authors:  Ondrej Havranek; Petra Kleiblova; Jan Hojny; Filip Lhota; Pavel Soucek; Marek Trneny; Zdenek Kleibl
Journal:  PLoS One       Date:  2015-10-27       Impact factor: 3.240

10.  A novel mutation in ornithine transcarbamylase gene causing mild intermittent hyperammonemia.

Authors:  Sarar Mohamed; Muddathir H Hamad; Altaf A Kondkar; Khaled K Abu-Amero
Journal:  Saudi Med J       Date:  2015-10       Impact factor: 1.484

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.